|
Dl
Dl
|
Dt
Dt
|
Dc
Dc
|
Dj
Dj
|
Dv
Dv
|
Ds
Ds
|
Dg
Dg
|
|---|---|---|---|---|---|---|
|
0 esdeveniments,
|
1 esdeveniment,
–
Engineering human pluripotent stem cells to understand kidney development and disease Lucía Selfa Aspiroz, Pluripotency for organ regeneration group This thesis defence will start at 10AM. If you wisth to attend to this PhD thesis defence, you can join here via zoom. |
0 esdeveniments,
|
0 esdeveniments,
|
1 esdeveniment,
–
El Nanodía Mundial Contra el Cáncer es un evento organizado en el marco del Día Mundial contra el Cáncer donde se darán a conocer las últimas innovaciones en materia de NANOMEDICINA contra el CÁNCER, con temas que van desde el diagnóstico precoz, la liberación controlada de fármacos o la radioterapia con nanopartículas. Un año más, expertos en NANOMEDICINA de diferentes ... Read more |
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
3 esdeveniments,
–
Biomechanics of the progression of colorectal carcinomas Giulia Fornabaio, Synthetic morphogenesis group According to the World Health Organization, cancer is one of the main causes of death worldwide, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells ... Read more
–
Biomechanics of the progression of colorectal carcinomas Giulia Fornabaio, Synthetic morphogenesis group According to the World Health Organization, cancer is one of the main causes of death worldwide, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells ... Read more
–
Biomechanics of the progression of colorectal carcinomas Giulia Fornabaio, Synthetic morphogenesis group According to the World Health Organization, cancer is one of the main causes of death worldwide, with colorectal carcinoma (CRC) being the second-leading cause of tumour related-death. The high rate of mortality of CRCs is principally attributed to the metastasis of neoplastic cells ... Read more |
0 esdeveniments,
|
0 esdeveniments,
|
|
1 esdeveniment,
–
Nano Rare Diseases Day es un evento organizado en el marco del Día Mundial de las Enfermedades Minoritarias donde se darán a conocer las últimas innovaciones en materia de Nanomedicina con temas que van desde el diagnóstico precoz, la liberación controlada de fármacos o el desarrollo de nuevas terapias. Durante esta jornada, expertos en Nanomedicina de diferentes campos ... Read more |
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
4 esdeveniments,
–
Regenerative Neuroimmunology - new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS Stefano Pulchino, University of Cambridge There are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel ... Read more
–
Regenerative Neuroimmunology - new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS Stefano Pulchino, University of Cambridge There are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel ... Read more
–
Regenerative Neuroimmunology - new generation molecular approaches to restore maladaptive inflammatory responses in the persistently inflamed CNS Stefano Pulchino, University of Cambridge There are currently no approved therapies to slow down the accumulation of neurological disability that occurs independently of relapses in multiple sclerosis (MS). International agencies are engaging to expedite the development of novel ... Read more |
0 esdeveniments,
|
0 esdeveniments,
|